Guild Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$222K Buy
+882
New +$190K 0.15% 55
2022
Q1
Sell
-37,322
Closed -$5.05M 78
2021
Q4
$5.05M Sell
37,322
-1,915
-5% -$226K 5.11% 3
2021
Q3
$4.23M Buy
39,237
+5,566
+17% +$636K 4.07% 5
2021
Q2
$3.79M Sell
33,671
-1,800
-5% -$203K 3.67% 7
2021
Q1
$3.84M Buy
35,471
+1,571
+5% +$168K 4.11% 5
2020
Q4
$3.63M Sell
33,900
-500
-1% -$48K 4% 5
2020
Q3
$3.01M Buy
34,400
+2,050
+6% +$193K 4.15% 5
2020
Q2
$3.18M Buy
32,350
+4,080
+14% +$359K 4.51% 5
2020
Q1
$2.15M Buy
+28,270
New +$2.41M 4.68% 6

Other funds holding ABBV

Guild Investment Management's ABBV Position: Q2 2026 in Review

Guild Investment Management opened a new position in AbbVie (ABBV) in Q2 2026: 882 shares worth $222K. The stake represents 0.15% of the portfolio and ranks #55 among its holdings. This is a return to the name: Guild Investment Management previously reported a position in ABBV as recently as Q4 2021.

Guild Investment Management first reported a position in ABBV in Q1 2020 and has held it in 9 quarters since. The position peaked at $5.05M in Q4 2021. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Guild Investment Management held 882 shares of AbbVie worth $222K as of Q2 2026.
  • AbbVie was a new Guild Investment Management position in Q2 2026.
  • AbbVie made up 0.15% of Guild Investment Management's portfolio in Q2 2026, its #55 holding.
  • Guild Investment Management first reported a position in AbbVie in Q1 2020 and has held it in 9 quarters since.
  • Guild Investment Management's AbbVie position peaked at $5.05M in Q4 2021.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Guild Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.